Emerging Strategies in TCR-Engineered T Cells

Emerging Strategies in TCR-Engineered T Cells

Immunotherapy of cancer has made tremendous progress in recent years, as demonstrated by the remarkable clinical responses obtained from adoptive cell transfer (ACT) of patient-derived tumor infiltrating lymphocytes, chimeric antigen receptor (CAR)-modified T cells (CAR-T) and T cell receptor (TCR)-...

Full description

Bibliographic Details
Main Authors: Fang Wei, Xiao-Xia Cheng, John Zhao Xue, Shao-An Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
T cell receptor
genetic engineering
cancer immunotherapy
TCR-engineering
new strategies
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.850358/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.850358/full

Similar Items